Generell weisst, Swissmedic darauf hin, dass einige Anbieter neue Peptid-Wirkstoffe vertreiben, deren Wirksamkeit noch nicht klinisch belegt ist
Our Aon measurement approach follows each patient in their journey recognizing unique starting points in each population
Rotate between left and right thigh and move at least 1 inch from any previous injection point
12-14 In phase III clinical studies in which exenatide was administered concomitantly with metformin, an SU, or metformin plus an SU, 48% of the 483 patients receiving exenatide 10 mcg twice daily reported nausea compared to 18% of the 483 patients receiving placebo
According to FDA prescribing information, nausea occurs in approximately 15-44% of patients depending on the specific agent and dose, with vomiting, diarrhea, constipation, and abdominal pain also frequently reported